A Network Pharmacology and Molecular Dynamics Simulation-Based Study of Qing Run Hua Jie Decoction in Interstitial Pneumonia Treatment

References

• Wong AW, Ryerson CJ, Guler SA. Progression of fibrosing interstitial lung disease. Respir Res. 2020;21(1):32. doi:10.1186/s12931-020-1296-3
   PubMed Web of Science ®Google Scholar
• Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188(6):733–748. doi:10.1164/rccm.201308-1483ST
   PubMed Web of Science ®Google Scholar
• Samarelli AV, Tonelli R, Marchioni A, et al. Fibrotic idiopathic interstitial lung disease: the molecular and cellular key players. Int J Mol Sci. 2021;22(16):8952. doi:10.3390/ijms22168952
   PubMed Web of Science ®Google Scholar
• Kim EJ, Elicker BM, Maldonado F, et al. Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J. 2010;35(6):1322–1328. doi:10.1183/09031936.00092309
   PubMed Web of Science ®Google Scholar
• Makino S. Progressive fibrosing interstitial lung diseases: a new concept and indication of nintedanib. Mod Rheumatol. 2021;31(1):13–19. doi:10.1080/14397595.2020.1826665
   PubMed Web of Science ®Google Scholar
• Hopkins AL. Network pharmacology. Nat Biotechnol. 2007;25:1110–1111. doi:10.1038/nbt1007-1110
   PubMed Web of Science ®Google Scholar
• Hopkins AL. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol. 2008;4(11):682–690. doi:10.1038/nchembio.118
   PubMed Web of Science ®Google Scholar
• Chen D, Zhang F, Tang S, et al. A network-based systematic study for the mechanism of the treatment of zhengs related to cough variant asthma. Evid Based Complement Alternat Med. 2013;2013:595924. doi:10.1155/2013/595924
   PubMed Web of Science ®Google Scholar
• Tang HC, Huang HJ, Lee CC, Chen CYC. Network pharmacology-based approach of novel traditional Chinese medicine formula for treatment of acute skin inflammation in silico. Comput Biol Chem. 2017;71:70–81. doi:10.1016/j.compbiolchem.2017.08.013
   PubMed Web of Science ®Google Scholar
• Shen QL. A study on 35 interstitial pneumonia patients treated with Qing Run Hua Jie decoction. J Emerg Tradit Chin Med. 2006;15:199–200. doi:10.3969/j.issn.1004-745X.2006.02.063
   Google Scholar
• Fang H, Gough J. The ‘dnet’ approach promotes emerging research on cancer patient survival. Genome Med. 2014;6(8):64. doi:10.1186/s13073-014-0064-8
   PubMedGoogle Scholar
• Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284–287. doi:10.1089/omi.2011.0118
   PubMed Web of Science ®Google Scholar
• Fan L, Feng S, Wang T, et al. Chemical composition and therapeutic mechanism of Xuanbai Chengqi Decoction in the treatment of COVID-19 by network pharmacology, molecular docking and molecular dynamic analysis. Mol Divers. 2023;27(1):81–102. doi:10.1007/s11030-022-10415-7
   PubMed Web of Science ®Google Scholar
• Alshehri B, Vijayakumar R, Senthilkumar S, et al. Molecular target prediction and docking of anti-thrombosis compounds and its activation on tissue-plasminogen activator to treat stroke. J King Saud Univ Sci. 2022;34(1):101732. doi:10.1016/j.jksus.2021.101732
   Web of Science ®Google Scholar
• Xiong G, Wu Z, Yi J, et al. ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Res. 2021;49(W1):W5–W14. doi:10.1093/nar/gkab255
   PubMed Web of Science ®Google Scholar
• Swargiary G, Mani S. ER and PGR targeting ability of phytocompounds derived from Centella asiatica and Andrographis paniculata: an in-silico approach. J Herbal Med. 2022;32:100541. doi:10.1016/j.hermed.2022.100541
   Web of Science ®Google Scholar
• Ye J, Li L, Hu Z, Xu B. Exploring the molecular mechanism of action of yinchen wuling powder for the treatment of hyperlipidemia, using network pharmacology, molecular docking, and molecular dynamics simulation. Biomed Res Int. 2021;2021:9965906. doi:10.1155/2021/9965906
   PubMed Web of Science ®Google Scholar
• Kushwaha PP, Singh AK, Bansal T, et al. Identification of natural inhibitors against SARS-CoV-2 drugable targets using molecular docking, molecular dynamics simulation, and MM-PBSA approach. Front Cell Infect Microbiol. 2021;11:730288. doi:10.3389/fcimb.2021.730288
   PubMed Web of Science ®Google Scholar
• Skjaerven L, Yao XQ, Scarabelli G, Grant BJ. Integrating protein structural dynamics and evolutionary analysis with Bio3D. BMC Bioinf. 2014;15:399. doi:10.1186/s12859-014-0399-6
   PubMed Web of Science ®Google Scholar
• Miura Y, Lam M, Bourke JE, Kanazawa S. Bimodal fibrosis in a novel mouse model of bleomycin-induced usual interstitial pneumonia. Life Sci Alliance. 2022;5(1):e202101059. doi:10.26508/lsa.202101059
   PubMed Web of Science ®Google Scholar
• Wang Y, Sun S, Wang K, et al. Interleukin-19 aggravates pulmonary fibrosis via activating fibroblast through TGF-beta/Smad pathway. Mediators Inflamm. 2022;2022:6755407. doi:10.1155/2022/6755407
   PubMed Web of Science ®Google Scholar
• Kang S, Tanaka T, Narazaki M, Kishimoto T. Targeting interleukin-6 signaling in clinic. Immunity. 2019;50(4):1007–1023. doi:10.1016/j.immuni.2019.03.026
   PubMed Web of Science ®Google Scholar
• Kang S, Narazaki M, Metwally H, Kishimoto T. Historical overview of the interleukin-6 family cytokine. J Exp Med. 2020;217. doi:10.1084/jem.20190347
   Web of Science ®Google Scholar
• Uciechowski P, Dempke WCM. Interleukin-6: a masterplayer in the cytokine network. Oncology. 2020;98:131–137. doi:10.1159/000505099
   PubMed Web of Science ®Google Scholar
• Aran V, Omerovic J. Current approaches in NSCLC targeting K-RAS and EGFR. Int J Mol Sci. 2019;20(22):5701. doi:10.3390/ijms20225701
   PubMed Web of Science ®Google Scholar
• Suresh MV, Balijepalli S, Zhang B, et al. Hypoxia-Inducible Factor (HIF)-1alpha promotes inflammation and injury following aspiration-induced lung injury in mice. Shock. 2019;52(6):612–621. doi:10.1097/SHK.0000000000001312
   PubMed Web of Science ®Google Scholar
• Epstein Shochet G, Bardenstein-Wald B, McElroy M, et al. Hypoxia inducible factor 1A supports a pro-fibrotic phenotype loop in idiopathic pulmonary fibrosis. Int J Mol Sci. 2021;22(7):3331. doi:10.3390/ijms22073331
   PubMed Web of Science ®Google Scholar
• Yang R, Yang H, Jiang D, et al. Investigation of the potential mechanism of the Shugan Xiaozhi decoction for the treatment of nonalcoholic fatty liver disease based on network pharmacology, molecular docking and molecular dynamics simulation. PeerJ. 2022;10:e14171. doi:10.7717/peerj.14171
   PubMed Web of Science ®Google Scholar
• Elkhalifa AEO, Banu H, Khan MI, Ashraf SA. Integrated network pharmacology, molecular docking, molecular simulation, and in vitro validation revealed the bioactive components in soy-fermented food products and the underlying mechanistic pathways in lung cancer. Nutrients. 2023;15(18):3949. doi:10.3390/nu15183949
   PubMed Web of Science ®Google Scholar
• Bisht A, Tewari D, Kumar S, Chandra S. Network pharmacology, molecular docking, and molecular dynamics simulation to elucidate the mechanism of anti-aging action of Tinospora cordifolia. Mol Divers. 2023. doi:10.1007/s11030-023-10684-w
   PubMed Web of Science ®Google Scholar
• Cai B, Zhang Y, Wang Z, et al. Therapeutic potential of diosgenin and its major derivatives against neurological diseases: recent advances. Oxid Med Cell Longev. 2020;2020:3153082. doi:10.1155/2020/3153082
   PubMed Web of Science ®Google Scholar
• Arya P, Kumar P. Diosgenin a steroidal compound: an emerging way to cancer management. J Food Biochem. 2021;45(12):e14005. doi:10.1111/jfbc.14005
   PubMed Web of Science ®Google Scholar
• Wu FC, Jiang JG. Effects of diosgenin and its derivatives on atherosclerosis. Food Funct. 2019;10:7022–7036. doi:10.1039/c9fo00749k
   PubMed Web of Science ®Google Scholar
• Sun F, Yang X, Ma C, et al. The effects of diosgenin on hypolipidemia and its underlying mechanism: a review. Diabetes Metab Syndr Obes. 2021;14:4015–4030. doi:10.2147/DMSO.S326054
   PubMed Web of Science ®Google Scholar
• Arya P, Kumar P. Diosgenin: an ingress towards solving puzzle for diabetes treatment. J Food Biochem. 2022;46(12):e14390. doi:10.1111/jfbc.14390
   PubMed Web of Science ®Google Scholar
• Du S, Li C, Lu Y, et al. Dioscin alleviates crystalline silica-induced pulmonary inflammation and fibrosis through promoting alveolar macrophage autophagy. Theranostics. 2019;9(7):1878–1892. doi:10.7150/thno.29682
   PubMed Web of Science ®Google Scholar
• Wu MM, Wang QM, Huang BY, et al. Dioscin ameliorates murine ulcerative colitis by regulating macrophage polarization. Pharmacol Res. 2021;172:105796. doi:10.1016/j.phrs.2021.105796
   PubMed Web of Science ®Google Scholar
• Huang X-F, Zhang J-L, Huang D-P, et al. A network pharmacology strategy to investigate the anti-inflammatory mechanism of luteolin combined with in vitro transcriptomics and proteomics. Int Immunopharmacol. 2020;86:106727. doi:10.1016/j.intimp.2020.106727
   PubMed Web of Science ®Google Scholar
• Ambrose GO, Afees OJ, Nwamaka NC, et al. Selection of Luteolin as a potential antagonist from molecular docking analysis of EGFR mutant. Bioinformation. 2018;14(05):241–247. doi:10.6026/97320630014241
   PubMedGoogle Scholar
• Wang S, Cao M, Xu S, et al. Luteolin alters macrophage polarization to inhibit inflammation. Inflammation. 2020;43(1):95–108. doi:10.1007/s10753-019-01099-7
   PubMed Web of Science ®Google Scholar
• Wu B, Song H, Fan M, et al. Luteolin attenuates sepsis-induced myocardial injury by enhancing autophagy in mice. Int J Mol Med. 2020;45(5):1477–1487. doi:10.3892/ijmm.2020.4536
   PubMed Web of Science ®Google Scholar
• Lee EJ, Oh SY, Sung MK. Luteolin exerts anti-tumor activity through the suppression of epidermal growth factor receptor-mediated pathway in MDA-MB-231 ER-negative breast cancer cells. Food Chem Toxicol. 2012;50:4136–4143. doi:10.1016/j.fct.2012.08.025
   PubMed Web of Science ®Google Scholar